Skip to content

IXHL - Incannex Healthcare Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchI

Incannex Healthcare Ltd ADR

IXHL · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

I

IXHLIncannex Healthcare Ltd ADR

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $27.69
52-wk low: $2.49
Prev close: $16.14
Mkt cap: $41.2M
Fwd P/E: 3.8x
Beta: 2.81

Smart money

3 funds hold a position.

Real smart money

Funds holding this stock

3 holders

Combined position$400K

MI
Millennium
Israel Englander · Q2 2026 13F
$358K
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Reported May 15, 2026

Earnings came in 41.7% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 3.78
Market cap: $41M

Valuation

P/S7764.11
P/B0.53

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: IXHL
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market cap: $41.16M
Beta: 2.81

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

7764.1x

P/B

0.5x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-117.2%

$39K

position

JC

JPMorgan Chase

Q1 2026 13F

$3K

position

Coverage gaps for IXHL

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.49+41.7%

-$0.84 expected

Next report

Reports Oct 5, 2026, in 45 days

EPS expected

-$0.51

-$0.51 to -$0.51

Revenue expected

$0.00

1 analysts

Estimate drift

0.51

Change in 30 days

-117.2%

ROA-32.2%

Growth

Beta2.81